Rheumatoid Arthritis Support

Tolerx, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company is focused on discovering and developing new therapies designed to treat patients by reprogramming the immune system, allowing for long-term remission of immune-related diseases after a short course of therapy. Targeted diseases include type 1 diabetes, rheumatoid arthritis, Inflammatory bowel disease (IBD), cancer, chronic and viral diseases. In 2008, Tolerx was named one of Fierce Biotech’s Fierce 15.


Adapted from the Wikipedia article Tolerx, under the G. N. U. Free Documentation License. Please also see http://en.wikipedia.org/wiki